NGS improves IVF success with healthier embryo selection with Dagan Wells | Illumina Video

5 November 2014

Trying to determine the health of an embryo by conventional microscopic methods has its limitations. With next-generation sequencing technologies and Preimplantation Genetic Screening (PGS) from Illumina, we can select healthier embryos that are more likely to result in successful pregnancies. illumina.com/clinical/reproductive-genetic-health.html
Learn about the latest advances in reproductive and genetic health from Illumina. Empowering informed choices to change lives.
Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.